<html>
<head>PUBMED IDs for PSMD2</head>
<body bgcolor='#C5F0F2'><h1>PSMD2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17004105/'>Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics.</a> September 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17004092/'>Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation.</a> September 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/21465578/'>Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas.</a> June 7  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22901813/'>Cancer vulnerabilities unveiled by genomic loss.</a> October 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23874428/'>Reconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma.</a> April 18  2013<br></body></html>
